marketcaparena

CNC

CENTENE CORP

Company overview

Market capitalization
$30.89B
Employees
61,000
Latest publication
2026-09-29
About CENTENE CORP

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ2 20232023-06-30 · USDQ1 20232023-03-31 · USD
Total Revenue53,579,000,000USD49,944,000,000USD46,620,000,000USD42,023,000,000USD39,836,000,000USD40,407,000,000USD37,608,000,000USD38,889,000,000USD
Cost Of Revenue729,000,000USD39,005,000,000USD41,418,000,000USD37,988,000,000USD35,407,000,000USD35,762,000,000USD33,078,000,000USD34,315,000,000USD
Gross Profit4,617,000,000USD10,939,000,000USD5,202,000,000USD4,035,000,000USD4,429,000,000USD4,645,000,000USD4,530,000,000USD4,574,000,000USD
Selling General Administrative3,103,000,000USD3,397,000,000USD3,353,000,000USD3,057,000,000USD2,894,000,000USD3,218,000,000USD3,016,000,000USD3,011,000,000USD
Other Operating Expenses12,623,000,000USD———————
Total Operating Expenses3,419,000,000USD9,078,000,000USD3,668,000,000USD3,370,000,000USD3,200,000,000USD3,539,000,000USD3,359,000,000USD3,356,000,000USD
Operating Income1,198,000,000USD1,861,000,000USD1,534,000,000USD665,000,000USD1,229,000,000USD1,106,000,000USD1,171,000,000USD1,218,000,000USD
Total Other Income Expense Net288,000,000USD238,000,000USD212,000,000USD256,000,000USD287,000,000USD367,000,000USD244,000,000USD173,000,000USD
Interest Expense153,000,000USD164,000,000USD170,000,000USD176,000,000USD176,000,000USD178,000,000USD181,000,000USD180,000,000USD
Income Before Tax1,486,000,000USD2,099,000,000USD1,746,000,000USD921,000,000USD1,516,000,000USD1,473,000,000USD1,415,000,000USD1,391,000,000USD
Income Tax Expense399,000,000USD560,000,000USD432,000,000USD211,000,000USD370,000,000USD315,000,000USD360,000,000USD261,000,000USD
Net Income1,087,000,000USD1,541,000,000USD1,311,000,000USD713,000,000USD1,146,000,000USD1,163,000,000USD1,058,000,000USD1,130,000,000USD
Minority Interest-4,000,000USD2,000,000USD-3,000,000USD3,000,000USD0USD5,000,000USD-3,000,000USD0USD
Net Income Applicable To Common Shares1,091,000,000USD—1,311,000,000USD713,000,000USD——1,058,000,000USD1,130,000,000USD
Unclassified Operating Expenses—5,681,000,000USD315,000,000USD313,000,000USD306,000,000USD321,000,000USD343,000,000USD345,000,000USD
Net Interest Income—-164,000,000USD-170,000,000USD-176,000,000USD-176,000,000USD-178,000,000USD-181,000,000USD-180,000,000USD
Tax Provision—560,000,000USD432,000,000USD211,000,000USD370,000,000USD315,000,000USD360,000,000USD261,000,000USD
Net Income From Continuing Ops—1,539,000,000USD1,314,000,000USD710,000,000USD1,146,000,000USD1,158,000,000USD1,055,000,000USD1,130,000,000USD
Ebit—2,263,000,000USD1,916,000,000USD1,097,000,000USD1,692,000,000USD1,651,000,000USD1,596,000,000USD1,571,000,000USD
Ebitda—2,563,000,000USD2,231,000,000USD1,410,000,000USD1,998,000,000USD1,959,000,000USD1,921,000,000USD1,896,000,000USD
Depreciation And Amortization—300,000,000USD315,000,000USD313,000,000USD306,000,000USD308,000,000USD325,000,000USD325,000,000USD
Reconciled Depreciation—300,000,000USD314,000,000USD313,000,000USD306,000,000USD308,000,000USD325,000,000USD346,000,000USD
Interest Income——170,000,000USD176,000,000USD——181,000,000USD180,000,000USD
Non Operating Income Net Other——————425,000,000USD353,000,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20162016-12-31 · USD
Total Revenue163,071,000,000USD153,999,000,000USD144,547,000,000USD125,982,000,000USD111,115,000,000USD74,639,000,000USD60,116,000,000USD40,607,000,000USD
Cost Of Revenue146,242,000,000USD122,458,000,000USD127,891,000,000USD111,783,000,000USD95,899,000,000USD65,796,000,000USD51,695,000,000USD35,063,000,000USD
Gross Profit16,829,000,000USD31,541,000,000USD16,656,000,000USD14,199,000,000USD15,216,000,000USD8,843,000,000USD8,421,000,000USD5,544,000,000USD
Selling General Administrative12,400,000,000USD12,273,000,000USD20,919,000,000USD10,166,000,000USD11,343,000,000USD6,533,000,000USD6,752,000,000USD4,134,000,000USD
Unclassified Operating Expenses1,254,000,000USD16,338,000,000USD-5,581,000,000USD1,684,000,000USD791,000,000USD529,000,000USD211,000,000USD147,000,000USD
Total Operating Expenses13,654,000,000USD28,611,000,000USD15,338,000,000USD12,415,000,000USD12,134,000,000USD7,062,000,000USD6,963,000,000USD4,281,000,000USD
Operating Income3,175,000,000USD2,930,000,000USD1,318,000,000USD1,784,000,000USD3,082,000,000USD1,781,000,000USD1,458,000,000USD1,263,000,000USD
Interest Income702,000,000USD725,000,000USD665,000,000USD665,000,000USD728,000,000USD412,000,000USD343,000,000USD217,000,000USD
Interest Expense702,000,000USD725,000,000USD665,000,000USD665,000,000USD728,000,000USD412,000,000USD343,000,000USD217,000,000USD
Net Interest Income-702,000,000USD-716,000,000USD-665,000,000USD-665,000,000USD-728,000,000USD-412,000,000USD-343,000,000USD-217,000,000USD
Income Before Tax4,257,000,000USD3,598,000,000USD1,962,000,000USD1,813,000,000USD2,773,000,000USD1,782,000,000USD1,368,000,000USD1,160,000,000USD
Income Tax Expense963,000,000USD899,000,000USD760,000,000USD477,000,000USD979,000,000USD473,000,000USD474,000,000USD599,000,000USD
Tax Provision963,000,000USD1,174,000,000USD760,000,000USD477,000,000USD979,000,000USD473,000,000USD474,000,000USD599,000,000USD
Net Income3,305,000,000USD2,702,000,000USD1,202,000,000USD1,347,000,000USD1,808,000,000USD1,321,000,000USD900,000,000USD562,000,000USD
Net Income From Continuing Ops3,294,000,000USD2,441,000,000USD1,202,000,000USD1,336,000,000USD1,794,000,000USD2,255,000,000USD894,000,000USD558,000,000USD
Ebit4,959,000,000USD2,930,000,000USD2,627,000,000USD2,478,000,000USD3,501,000,000USD2,194,000,000USD1,711,000,000USD1,377,000,000USD
Ebitda6,200,000,000USD2,930,000,000USD4,058,000,000USD3,813,000,000USD4,760,000,000USD2,837,000,000USD2,206,000,000USD1,655,000,000USD
Depreciation And Amortization1,241,000,000USD1,293,000,000USD1,431,000,000USD1,335,000,000USD1,259,000,000USD643,000,000USD495,000,000USD278,000,000USD
Reconciled Depreciation1,241,000,000USD1,452,000,000USD1,553,000,000USD1,476,000,000USD1,259,000,000USD643,000,000USD495,000,000USD—
Total Other Income Expense Net1,082,000,000USD668,000,000USD644,000,000USD29,000,000USD-309,000,000USD1,000,000USD-90,000,000USD-103,000,000USD
Minority Interest11,000,000USD3,000,000USD3,000,000USD11,000,000USD-14,000,000USD-12,000,000USD-6,000,000USD-1,000,000USD
Net Income Applicable To Common Shares3,305,000,000USD2,702,000,000USD1,202,000,000USD1,347,000,000USD1,808,000,000USD1,321,000,000USD900,000,000USD562,000,000USD
Non Operating Income Net Other——1,279,000,000USD819,000,000USD480,000,000USD413,000,000USD253,000,000USD114,000,000USD
Selling And Marketing Expenses———565,000,000USD————
Research Development——————0USD0USD
Discontinued Operations———————3,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets83,012,000,000USD81,175,000,000USD77,661,000,000USD82,087,000,000USD86,395,000,000USD87,044,000,000USD82,445,000,000USD82,351,000,000USD
Cash And Equivalents24,151,000,000USD—17,888,000,000USD17,058,000,000USD14,513,000,000USD14,815,000,000USD14,063,000,000USD14,577,000,000USD
Cash And Short Term Investments27,057,000,000USD23,741,000,000USD17,888,000,000USD19,237,000,000USD17,281,000,000USD17,287,000,000USD16,685,000,000USD17,569,000,000USD
Short Term Investments2,906,000,000USD2,477,000,000USD2,432,000,000USD2,179,000,000USD2,768,000,000USD2,472,000,000USD2,622,000,000USD2,992,000,000USD
Long Term Investments16,302,000,000USD16,599,000,000USD17,035,000,000USD18,180,000,000USD18,797,000,000USD18,268,000,000USD17,429,000,000USD17,691,000,000USD
Total Current Assets46,685,000,000USD44,989,000,000USD35,993,000,000USD44,062,000,000USD40,389,000,000USD41,288,000,000USD37,999,000,000USD37,409,000,000USD
Other Current Assets1,552,000,000USD1,822,000,000USD20,050,000,000USD1,716,000,000USD1,556,000,000USD1,565,000,000USD1,601,000,000USD1,559,000,000USD
Other Non Current Assets1,370,000,000USD———————
Total Liabilities60,355,000,000USD———————
Total Current Liabilities40,759,000,000USD40,045,000,000USD21,476,000,000USD40,630,000,000USD36,786,000,000USD37,143,000,000USD34,261,000,000USD34,061,000,000USD
Other Non Current Liabilities2,810,000,000USD———————
Total Stockholder Equity22,562,000,000USD21,427,000,000USD19,953,000,000USD20,948,000,000USD27,406,000,000USD27,916,000,000USD26,410,000,000USD27,307,000,000USD
Total Equity Including Noncontrolling Interest22,657,000,000USD———————
Short Long Term Debt150,000,000USD63,000,000USD50,000,000USD38,000,000USD25,000,000USD12,000,000USD110,000,000USD111,000,000USD
Long Term Debt16,030,000,000USD16,308,000,000USD17,351,000,000USD17,545,000,000USD17,552,000,000USD18,308,000,000USD18,423,000,000USD17,494,000,000USD
Deferred Revenue706,000,000USD———————
Property Plant Equipment Net2,130,000,000USD2,090,000,000USD2,354,000,000USD2,161,000,000USD2,122,000,000USD2,044,000,000USD2,426,000,000USD2,042,000,000USD
Goodwill10,835,000,000USD———————
Intangible Assets4,203,000,000USD4,364,000,000USD4,530,000,000USD4,840,000,000USD5,010,000,000USD5,236,000,000USD5,409,000,000USD5,582,000,000USD
Accounts Payable17,965,000,000USD16,832,000,000USD20,544,000,000USD16,875,000,000USD13,520,000,000USD13,948,000,000USD13,016,000,000USD13,338,000,000USD
Common Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
Retained Earnings11,306,000,000USD10,215,000,000USD8,674,000,000USD9,775,000,000USD16,406,000,000USD16,659,000,000USD15,348,000,000USD15,065,000,000USD
Accumulated Other Comprehensive Income-194,000,000USD-171,000,000USD-58,000,000USD-100,000,000USD-231,000,000USD-337,000,000USD-504,000,000USD-226,000,000USD
Total Liab—59,648,000,000USD57,605,000,000USD61,032,000,000USD58,892,000,000USD59,025,000,000USD55,935,000,000USD54,942,000,000USD
Other Current Liab—22,197,000,000USD-50,000,000USD23,061,000,000USD22,559,000,000USD22,314,000,000USD20,316,000,000USD19,954,000,000USD
Capital Stock—1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
Good Will—10,835,000,000USD10,835,000,000USD10,835,000,000USD17,558,000,000USD17,558,000,000USD17,558,000,000USD17,558,000,000USD
Cash—21,264,000,000USD17,888,000,000USD17,058,000,000USD14,513,000,000USD14,815,000,000USD14,063,000,000USD14,577,000,000USD
Current Deferred Revenue—953,000,000USD736,000,000USD656,000,000USD682,000,000USD869,000,000USD661,000,000USD658,000,000USD
Net Debt—-4,893,000,000USD889,000,000USD525,000,000USD3,064,000,000USD3,505,000,000USD5,366,000,000USD3,028,000,000USD
Short Term Debt—63,000,000USD196,000,000USD38,000,000USD25,000,000USD12,000,000USD268,000,000USD111,000,000USD
Short Long Term Debt Total—16,371,000,000USD18,777,000,000USD17,583,000,000USD17,577,000,000USD18,320,000,000USD19,429,000,000USD17,605,000,000USD
Net Receivables—19,426,000,000USD18,105,000,000USD23,109,000,000USD21,552,000,000USD22,436,000,000USD19,713,000,000USD18,281,000,000USD
Common Stock Shares Outstanding—495,591,000shares491,071,428shares491,141,000shares493,548,000shares498,180,000shares501,978,000shares523,542,000shares
Non Current Assets Total—36,186,000,000USD41,668,000,000USD38,025,000,000USD46,006,000,000USD45,756,000,000USD44,446,000,000USD44,942,000,000USD
Non Current Liabilities Total—19,603,000,000USD36,129,000,000USD20,402,000,000USD22,106,000,000USD21,882,000,000USD21,674,000,000USD20,881,000,000USD
Non Current Liabilities Other—2,551,000,000USD1,196,000,000USD2,047,000,000USD3,903,000,000USD2,866,000,000USD1,829,000,000USD2,618,000,000USD
Non Currrent Assets Other—2,298,000,000USD2,156,000,000USD2,009,000,000USD2,519,000,000USD2,650,000,000USD1,624,000,000USD2,069,000,000USD
Net Working Capital—4,944,000,000USD3,674,000,000USD3,432,000,000USD3,603,000,000USD4,145,000,000USD3,738,000,000USD3,348,000,000USD
Unclassified Non Current Liabilities—744,000,000USD17,582,000,000USD810,000,000USD651,000,000USD708,000,000USD1,422,000,000USD769,000,000USD
Unclassified Equity—11,381,000,000USD11,335,000,000USD11,271,000,000USD11,229,000,000USD11,592,000,000USD11,564,000,000USD12,466,000,000USD
Other Assets——1,940,000,000USD2,009,000,000USD86,395,000,000USD2,650,000,000USD1,624,000,000USD2,069,000,000USD
Property Plant Equipment Gross——4,586,000,000USD———5,229,000,000USD—
Unclassified Current Assets——-22,482,000,000USD—————
Unclassified Non Current Assets——2,818,000,000USD-2,009,000,000USD-86,395,000,000USD-2,650,000,000USD-1,624,000,000USD-2,069,000,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets77,661,000,000USD82,445,000,000USD84,641,000,000USD76,870,000,000USD78,375,000,000USD68,719,000,000USD40,994,000,000USD30,901,000,000USD
Intangible Assets4,530,000,000USD5,409,000,000USD6,101,000,000USD6,911,000,000USD7,824,000,000USD8,388,000,000USD2,063,000,000USD2,239,000,000USD
Other Current Assets20,050,000,000USD1,601,000,000USD5,572,000,000USD2,461,000,000USD1,602,000,000USD1,317,000,000USD1,090,000,000USD784,000,000USD
Total Liab57,605,000,000USD55,935,000,000USD58,685,000,000USD52,633,000,000USD51,353,000,000USD42,757,000,000USD28,302,000,000USD19,878,000,000USD
Total Stockholder Equity19,953,000,000USD26,410,000,000USD25,840,000,000USD24,057,000,000USD26,795,000,000USD25,773,000,000USD12,551,000,000USD10,917,000,000USD
Other Current Liab-50,000,000USD20,316,000,000USD19,462,000,000USD18,379,000,000USD16,571,000,000USD13,692,000,000USD8,297,000,000USD7,497,000,000USD
Common Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD0USD7,449,000,000USD
Capital Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD0USD0USD
Retained Earnings8,674,000,000USD15,348,000,000USD12,043,000,000USD9,341,000,000USD8,139,000,000USD6,792,000,000USD4,984,000,000USD3,663,000,000USD
Good Will10,835,000,000USD17,558,000,000USD17,558,000,000USD18,812,000,000USD19,771,000,000USD18,652,000,000USD6,863,000,000USD7,015,000,000USD
Other Assets1,940,000,000USD1,624,000,000USD1,525,000,000USD1,217,000,000USD4,849,000,000USD2,659,000,000USD1,236,000,000USD1,082,000,000USD
Cash17,888,000,000USD14,063,000,000USD17,193,000,000USD12,074,000,000USD13,118,000,000USD10,800,000,000USD12,123,000,000USD5,342,000,000USD
Cash And Equivalents17,888,000,000USD14,063,000,000USD17,193,000,000USD12,074,000,000USD13,118,000,000USD10,800,000,000USD12,123,000,000USD5,342,000,000USD
Cash And Short Term Investments17,888,000,000USD16,685,000,000USD19,652,000,000USD14,395,000,000USD14,657,000,000USD12,380,000,000USD12,986,000,000USD6,064,000,000USD
Total Current Assets35,993,000,000USD37,999,000,000USD40,756,000,000USD30,128,000,000USD28,497,000,000USD23,393,000,000USD20,323,000,000USD11,998,000,000USD
Total Current Liabilities21,476,000,000USD34,261,000,000USD36,716,000,000USD28,464,000,000USD25,765,000,000USD21,585,000,000USD12,932,000,000USD11,971,000,000USD
Current Deferred Revenue736,000,000USD661,000,000USD715,000,000USD478,000,000USD434,000,000USD523,000,000USD383,000,000USD385,000,000USD
Net Debt889,000,000USD5,366,000,000USD1,684,000,000USD9,259,000,000USD9,543,000,000USD7,517,000,000USD2,386,000,000USD1,344,000,000USD
Short Term Debt196,000,000USD268,000,000USD287,000,000USD262,000,000USD471,000,000USD301,000,000USD249,000,000USD38,000,000USD
Short Long Term Debt50,000,000USD110,000,000USD119,000,000USD82,000,000USD267,000,000USD97,000,000USD88,000,000USD38,000,000USD
Short Long Term Debt Total18,777,000,000USD19,429,000,000USD18,877,000,000USD21,333,000,000USD22,661,000,000USD18,317,000,000USD14,509,000,000USD6,686,000,000USD
Long Term Debt17,351,000,000USD18,423,000,000USD17,710,000,000USD17,938,000,000USD18,571,000,000USD16,682,000,000USD13,638,000,000USD6,648,000,000USD
Long Term Investments17,035,000,000USD17,429,000,000USD16,286,000,000USD14,684,000,000USD14,043,000,000USD12,853,000,000USD7,717,000,000USD6,861,000,000USD
Short Term Investments2,432,000,000USD2,622,000,000USD2,459,000,000USD2,321,000,000USD1,539,000,000USD1,580,000,000USD863,000,000USD722,000,000USD
Net Receivables18,105,000,000USD19,713,000,000USD15,532,000,000USD13,272,000,000USD12,238,000,000USD9,696,000,000USD6,247,000,000USD5,150,000,000USD
Accounts Payable20,544,000,000USD13,016,000,000USD16,252,000,000USD9,345,000,000USD8,289,000,000USD7,069,000,000USD4,003,000,000USD4,051,000,000USD
Property Plant Equipment Net2,354,000,000USD2,426,000,000USD2,415,000,000USD4,986,000,000USD6,957,000,000USD2,774,000,000USD2,782,000,000USD1,706,000,000USD
Property Plant Equipment Gross4,586,000,000USD5,229,000,000USD4,419,000,000USD2,432,000,000USD3,391,000,000USD4,085,000,000USD2,121,000,000USD1,706,000,000USD
Accumulated Other Comprehensive Income-58,000,000USD-504,000,000USD-652,000,000USD-1,132,000,000USD77,000,000USD337,000,000USD134,000,000USD-56,000,000USD
Common Stock Shares Outstanding491,071,000shares523,744,000shares545,704,000shares582,040,000shares590,516,000shares579,135,000shares420,409,000shares398,506,000shares
Non Current Assets Total41,668,000,000USD44,446,000,000USD43,885,000,000USD46,742,000,000USD49,878,000,000USD45,326,000,000USD20,671,000,000USD18,903,000,000USD
Non Current Liabilities Total36,129,000,000USD21,674,000,000USD21,969,000,000USD24,169,000,000USD25,588,000,000USD21,172,000,000USD15,370,000,000USD7,907,000,000USD
Non Current Liabilities Other1,196,000,000USD1,829,000,000USD3,618,000,000USD5,616,000,000USD5,610,000,000USD2,956,000,000USD1,732,000,000USD1,259,000,000USD
Non Currrent Assets Other2,156,000,000USD1,624,000,000USD1,525,000,000USD1,349,000,000USD1,283,000,000USD2,659,000,000USD1,246,000,000USD1,082,000,000USD
Net Working Capital3,674,000,000USD3,738,000,000USD4,040,000,000USD1,664,000,000USD2,732,000,000USD1,808,000,000USD7,391,000,000USD27,000,000USD
Unclassified Current Assets-22,482,000,000USD———————
Unclassified Non Current Assets2,818,000,000USD-1,624,000,000USD-1,525,000,000USD-1,217,000,000USD-4,849,000,000USD-2,659,000,000USD-1,236,000,000USD-1,082,000,000USD
Unclassified Non Current Liabilities17,582,000,000USD1,422,000,000USD641,000,000USD-2,483,000,000USD-5,610,000,000USD-2,956,000,000USD-1,099,000,000USD-1,164,000,000USD
Unclassified Equity11,335,000,000USD11,564,000,000USD14,447,000,000USD20,059,000,000USD19,671,000,000USD19,458,000,000USD7,647,000,000USD—
Inventory——-35,184,000,000USD—————
Other Liab———3,098,000,000USD7,017,000,000USD4,490,000,000USD1,099,000,000USD1,164,000,000USD
Treasury Stock———-4,213,000,000USD-1,094,000,000USD-816,000,000USD-214,000,000USD-139,000,000USD
Net Tangible Assets———-1,610,000,000USD-800,000,000USD-1,190,000,000USD3,658,000,000USD1,673,000,000USD
Unclassified Current Liabilities————-267,000,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation600,000,000USD
Stock Based Compensation126,000,000USD
Deferred Income Tax-34,000,000USD
Other Non Cash Items1,000,000USD
Change To Liabilities5,411,000,000USD
Change In Working Capital3,761,000,000USD
Operating Cash Flow7,956,000,000USD
Capital Expenditures-374,000,000USD
Net Investments110,000,000USD
Investing Cash Flow-264,000,000USD
Net Debt Issuance-1,304,000,000USD
Net Common Stock Issuance-33,000,000USD
Other Financing Activities-3,000,000USD
Unclassified Financing Cash Flow18,000,000USD
Financing Cash Flow-1,322,000,000USD
Change In Cash6,370,000,000USD
End Cash Flow24,254,000,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income1,539,000,000USD-1,101,000,000USD-6,632,000,000USD-259,000,000USD1,314,000,000USD275,000,000USD710,000,000USD1,146,000,000USD
Depreciation300,000,000USD1,275,000,000USD317,000,000USD315,000,000USD314,000,000USD314,000,000USD313,000,000USD306,000,000USD
Stock Based Compensation67,000,000USD58,000,000USD52,000,000USD35,000,000USD59,000,000USD31,000,000USD49,000,000USD62,000,000USD
Other Non Cash Items7,000,000USD815,000,000USD9,042,000,000USD66,000,000USD15,000,000USD6,000,000USD9,000,000USD-14,000,000USD
Change To Account Receivables-1,353,000,000USD4,818,000,000USD-1,537,000,000USD883,000,000USD-2,684,000,000USD-1,596,000,000USD-1,678,000,000USD152,000,000USD
Change In Working Capital1,740,000,000USD723,000,000USD-1,552,000,000USD1,717,000,000USD-165,000,000USD-1,212,000,000USD-2,033,000,000USD739,000,000USD
Total Cash From Operating Activities3,600,000,000USD437,000,000USD1,356,000,000USD1,785,000,000USD1,510,000,000USD-587,000,000USD-978,000,000USD2,175,000,000USD
Capital Expenditures-200,000,000USD-213,000,000USD-211,000,000USD-208,000,000USD-135,000,000USD-154,000,000USD-153,000,000USD-186,000,000USD
Free Cash Flow3,400,000,000USD224,000,000USD1,145,000,000USD1,577,000,000USD1,375,000,000USD-741,000,000USD-1,131,000,000USD1,989,000,000USD
Investments289,000,000USD873,000,000USD1,240,000,000USD-899,000,000USD-529,000,000USD102,000,000USD-839,000,000USD-1,167,000,000USD
Total Cashflows From Investing Activities89,000,000USD660,000,000USD1,221,000,000USD-899,000,000USD-529,000,000USD102,000,000USD-839,000,000USD-1,167,000,000USD
Net Borrowings-1,046,000,000USD-187,000,000USD-1,000,000USD-749,000,000USD-208,000,000USD922,000,000USD-29,000,000USD—
Total Cash From Financing Activities-1,063,000,000USD-187,000,000USD9,000,000USD-1,174,000,000USD-250,000,000USD-13,000,000USD-1,245,000,000USD-1,171,000,000USD
Sale Purchase Of Stock-29,000,000USD-2,000,000USD-444,000,000USD-432,000,000USD-41,000,000USD-943,000,000USD-1,227,000,000USD-803,000,000USD
Issuance Of Capital Stock10,000,000USD8,000,000USD11,000,000USD8,000,000USD10,000,000USD9,000,000USD12,000,000USD11,000,000USD
Change In Cash2,630,000,000USD830,000,000USD2,545,000,000USD-302,000,000USD752,000,000USD-514,000,000USD-3,028,000,000USD20,000,000USD
Begin Period Cash Flow17,957,000,000USD17,058,000,000USD14,513,000,000USD14,815,000,000USD14,063,000,000USD14,577,000,000USD17,605,000,000USD17,585,000,000USD
End Period Cash Flow20,587,000,000USD17,888,000,000USD17,058,000,000USD14,513,000,000USD14,815,000,000USD14,063,000,000USD14,577,000,000USD17,605,000,000USD
Other Cashflows From Financing Activities2,000,000USD-6,000,000USD-1,000,000USD-1,000,000USD-11,000,000USD-1,000,000USD-1,000,000USD-1,000,000USD
Unclassified Operating Cash Flow-53,000,000USD-1,333,000,000USD129,000,000USD-89,000,000USD-27,000,000USD—-26,000,000USD-64,000,000USD
Other Cashflows From Investing Activities—1,239,000,000USD366,000,000USD-1,085,000,000USD-394,000,000USD-408,000,000USD-664,000,000USD-981,000,000USD
Unclassified Investing Cash Flow—-1,239,000,000USD-174,000,000USD1,293,000,000USD529,000,000USD562,000,000USD817,000,000USD1,167,000,000USD
Unclassified Financing Cash Flow—8,000,000USD455,000,000USD—10,000,000USD9,000,000USD—-367,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-6,677,000,000USD3,294,000,000USD2,702,000,000USD1,202,000,000USD1,336,000,000USD1,794,000,000USD1,309,000,000USD894,000,000USD
Depreciation1,275,000,000USD1,241,000,000USD1,293,000,000USD1,553,000,000USD1,476,000,000USD1,259,000,000USD643,000,000USD495,000,000USD
Stock Based Compensation204,000,000USD212,000,000USD216,000,000USD234,000,000USD203,000,000USD281,000,000USD177,000,000USD145,000,000USD
Other Non Cash Items9,523,000,000USD-91,000,000USD546,000,000USD1,709,000,000USD-54,000,000USD25,000,000USD301,000,000USD1,000,000,000USD
Change To Account Receivables1,480,000,000USD-4,333,000,000USD-2,380,000,000USD-1,627,000,000USD-2,453,000,000USD-52,000,000USD-1,076,000,000USD-1,173,000,000USD
Change In Working Capital823,000,000USD-4,515,000,000USD3,374,000,000USD2,194,000,000USD1,376,000,000USD2,195,000,000USD-1,002,000,000USD-171,000,000USD
Total Cash From Operating Activities5,088,000,000USD154,000,000USD8,053,000,000USD6,261,000,000USD4,205,000,000USD5,503,000,000USD1,483,000,000USD1,234,000,000USD
Capital Expenditures-767,000,000USD-644,000,000USD-799,000,000USD-1,004,000,000USD-910,000,000USD-869,000,000USD-730,000,000USD-675,000,000USD
Free Cash Flow4,321,000,000USD-490,000,000USD7,254,000,000USD5,257,000,000USD3,295,000,000USD4,634,000,000USD753,000,000USD559,000,000USD
Investments1,239,000,000USD-1,052,000,000USD-21,000,000USD-2,921,000,000USD-3,299,000,000USD-2,481,000,000USD-766,000,000USD-1,855,000,000USD
Total Cashflows From Investing Activities453,000,000USD-1,052,000,000USD-1,279,000,000USD-2,921,000,000USD-3,299,000,000USD-6,955,000,000USD-1,532,000,000USD-4,585,000,000USD
Net Borrowings-1,145,000,000USD678,000,000USD19,000,000USD-1,144,000,000USD1,833,000,000USD839,000,000USD6,870,000,000USD1,969,000,000USD
Total Cash From Financing Activities-1,602,000,000USD-2,406,000,000USD-1,570,000,000USD-4,197,000,000USD1,362,000,000USD260,000,000USD6,811,000,000USD4,686,000,000USD
Sale Purchase Of Stock-475,000,000USD-3,124,000,000USD-1,633,000,000USD-3,096,000,000USD-297,000,000USD-626,000,000USD-75,000,000USD-71,000,000USD
Issuance Of Capital Stock37,000,000USD46,000,000USD40,000,000USD70,000,000USD35,000,000USD0USD0USD2,779,000,000USD
Change In Cash3,825,000,000USD-3,130,000,000USD5,119,000,000USD-1,044,000,000USD2,318,000,000USD-1,323,000,000USD6,781,000,000USD1,270,000,000USD
Begin Period Cash Flow14,156,000,000USD17,193,000,000USD12,074,000,000USD13,118,000,000USD10,800,000,000USD12,123,000,000USD5,342,000,000USD4,072,000,000USD
End Period Cash Flow17,957,000,000USD14,063,000,000USD17,193,000,000USD12,074,000,000USD13,118,000,000USD10,800,000,000USD12,123,000,000USD5,342,000,000USD
Other Cashflows From Investing Activities1,239,000,000USD990,000,000USD-392,000,000USD-457,000,000USD19,000,000USD-22,000,000USD-766,000,000USD-1,855,000,000USD
Other Cashflows From Financing Activities-19,000,000USD-6,000,000USD-88,000,000USD-41,000,000USD-102,000,000USD-34,000,000USD16,000,000USD9,000,000USD
Unclassified Operating Cash Flow-60,000,000USD13,000,000USD—-631,000,000USD-132,000,000USD—55,000,000USD-1,129,000,000USD
Unclassified Investing Cash Flow-1,258,000,000USD-346,000,000USD-67,000,000USD1,461,000,000USD891,000,000USD-3,583,000,000USD730,000,000USD-200,000,000USD
Unclassified Financing Cash Flow37,000,000USD46,000,000USD220,000,000USD84,000,000USD-37,000,000USD81,000,000USD—8,856,000,000USD
Change To Inventory——2,122,000,000USD—-1,141,000,000USD-585,000,000USD421,000,000USD1,545,000,000USD
Dividends Paid——-88,000,000USD—-35,000,000USD——-6,077,000,000USD
Change To Liabilities———3,660,000,000USD1,032,000,000USD2,780,000,000USD342,000,000USD1,050,000,000USD
Cash And Cash Equivalents Changes———-857,000,000USD2,268,000,000USD-1,192,000,000USD6,783,000,000USD1,261,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductHealth Care Premium43,582,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductServices793,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentAll Other Segments1,196,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentCommercial9,356,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentMedicaid31,970,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentMedicare11,057,000,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductHealth Care Premium43,887,000,000USD0001071739-26-000098
Q1 2026Quarterly · 2026-03-31ProductServices768,000,000USD0001071739-26-000098
Q1 2026Quarterly · 2026-03-31SegmentAll Other Segments1,177,000,000USD0001071739-26-000098
Q1 2026Quarterly · 2026-03-31SegmentCommercial9,556,000,000USD0001071739-26-000098
Q1 2026Quarterly · 2026-03-31SegmentMedicaid28,885,000,000USD0001071739-26-000098
Q1 2026Quarterly · 2026-03-31SegmentMedicare10,326,000,000USD0001071739-26-000098
Q4 2025Quarterly · 2025-12-31ProductHealth Care Premium43,978,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductServices749,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentAll Other Segments1,280,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentCommercial10,792,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentMedicaid28,043,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentMedicare9,610,000,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductHealth Care Premium171,556,000,000USD0001071739-26-000049
FY 2025Yearly · 2025-12-31ProductServices3,025,000,000USD0001071739-26-000049
FY 2025Yearly · 2025-12-31SegmentAll Other Segments5,130,000,000USD0001071739-26-000049
FY 2025Yearly · 2025-12-31SegmentCommercial42,003,000,000USD0001071739-26-000049
FY 2025Yearly · 2025-12-31SegmentMedicaid110,434,000,000USD0001071739-26-000049
FY 2025Yearly · 2025-12-31SegmentMedicare37,210,000,000USD0001071739-26-000049
Q3 2025Quarterly · 2025-09-30ProductHealth Care Premium44,126,000,000USD0001071739-25-000183
Q3 2025Quarterly · 2025-09-30ProductServices772,000,000USD0001071739-25-000183
Q3 2025Quarterly · 2025-09-30SegmentAll Other Segments1,344,000,000USD0001071739-25-000183
Q3 2025Quarterly · 2025-09-30SegmentCommercial10,992,000,000USD0001071739-25-000183
Q3 2025Quarterly · 2025-09-30SegmentMedicaid27,963,000,000USD0001071739-25-000183
Q3 2025Quarterly · 2025-09-30SegmentMedicare9,391,000,000USD0001071739-25-000183
Q2 2025Quarterly · 2025-06-30ProductHealth Care Premium41,740,000,000USD0001071739-25-000150
Q2 2025Quarterly · 2025-06-30ProductServices727,000,000USD0001071739-25-000150
Q2 2025Quarterly · 2025-06-30SegmentAll Other Segments1,224,000,000USD0001071739-25-000150
Q2 2025Quarterly · 2025-06-30SegmentCommercial10,070,000,000USD0001071739-25-000150
Q2 2025Quarterly · 2025-06-30SegmentMedicaid27,998,000,000USD0001071739-25-000150
Q2 2025Quarterly · 2025-06-30SegmentMedicare9,450,000,000USD0001071739-25-000150
Q1 2025Quarterly · 2025-03-31ProductHealth Care Premium41,712,000,000USD0001071739-26-000098
Q1 2025Quarterly · 2025-03-31ProductServices777,000,000USD0001071739-26-000098
Q1 2025Quarterly · 2025-03-31SegmentAll Other Segments1,282,000,000USD0001071739-26-000098
Q1 2025Quarterly · 2025-03-31SegmentCommercial10,149,000,000USD0001071739-26-000098
Q1 2025Quarterly · 2025-03-31SegmentMedicaid26,430,000,000USD0001071739-26-000098
Q1 2025Quarterly · 2025-03-31SegmentMedicare8,759,000,000USD0001071739-26-000098
Q4 2024Quarterly · 2024-12-31ProductHealth Care Premium35,519,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductServices777,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentAll Other Segments1,272,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentCommercial8,723,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentMedicaid25,334,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentMedicare5,476,000,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductHealth Care Premium142,303,000,000USD0001071739-26-000049
FY 2024Yearly · 2024-12-31ProductServices3,202,000,000USD0001071739-26-000049
FY 2024Yearly · 2024-12-31SegmentAll Other Segments4,920,000,000USD0001071739-26-000049
FY 2024Yearly · 2024-12-31SegmentCommercial33,702,000,000USD0001071739-26-000049
FY 2024Yearly · 2024-12-31SegmentMedicaid101,417,000,000USD0001071739-26-000049
FY 2024Yearly · 2024-12-31SegmentMedicare23,032,000,000USD0001071739-26-000049
Q3 2024Quarterly · 2024-09-30ProductHealth Care Premium36,115,000,000USD0001071739-25-000183
Q3 2024Quarterly · 2024-09-30ProductServices784,000,000USD0001071739-25-000183
Q3 2024Quarterly · 2024-09-30SegmentAll Other Segments1,247,000,000USD0001071739-25-000183
Q3 2024Quarterly · 2024-09-30SegmentCommercial8,693,000,000USD0001071739-25-000183
Q3 2024Quarterly · 2024-09-30SegmentMedicaid26,440,000,000USD0001071739-25-000183
Q3 2024Quarterly · 2024-09-30SegmentMedicare5,643,000,000USD0001071739-25-000183
FY 2023Yearly · 2023-12-31ProductHealth Care Premium135,636,000,000USD0001071739-26-000049
FY 2023Yearly · 2023-12-31ProductServices4,459,000,000USD0001071739-26-000049
FY 2023Yearly · 2023-12-31SegmentAll Other Segments6,134,000,000USD0001071739-26-000049
FY 2023Yearly · 2023-12-31SegmentCommercial24,845,000,000USD0001071739-26-000049
FY 2023Yearly · 2023-12-31SegmentMedicaid100,759,000,000USD0001071739-26-000049
FY 2023Yearly · 2023-12-31SegmentMedicare22,261,000,000USD0001071739-26-000049
FY 2022Yearly · 2022-12-31ProductHealth Care Premium127,131,000,000USD0001071739-25-000027
FY 2022Yearly · 2022-12-31ProductServices8,348,000,000USD0001071739-25-000027
FY 2022Yearly · 2022-12-31SegmentAll Other Segments11,532,000,000USD0001071739-25-000027
FY 2022Yearly · 2022-12-31SegmentCommercial17,380,000,000USD0001071739-25-000027
FY 2022Yearly · 2022-12-31SegmentMedicaid93,151,000,000USD0001071739-25-000027
FY 2022Yearly · 2022-12-31SegmentMedicare22,484,000,000USD0001071739-25-000027
FY 2021Yearly · 2021-12-31ProductHealth Care Premium112,319,000,000USD0001071739-24-000037
FY 2021Yearly · 2021-12-31ProductServices5,664,000,000USD0001071739-24-000037
FY 2021Yearly · 2021-12-31SegmentAll Other Segments7,375,000,000USD0001071739-24-000037
FY 2021Yearly · 2021-12-31SegmentCommercial16,956,000,000USD0001071739-24-000037
FY 2021Yearly · 2021-12-31SegmentMedicaid84,139,000,000USD0001071739-24-000037
FY 2021Yearly · 2021-12-31SegmentMedicare17,512,000,000USD0001071739-24-000037
FY 2020Yearly · 2020-12-31ProductHealth Care Premium100,055,000,000USD0001071739-23-000047
FY 2020Yearly · 2020-12-31ProductServices3,745,000,000USD0001071739-23-000047
FY 2019Yearly · 2019-12-31ProductHealth Care Premium67,439,000,000USD0001071739-22-000071
FY 2019Yearly · 2019-12-31ProductServices2,925,000,000USD0001071739-22-000071
FY 2018Yearly · 2018-12-31ProductHealth Care Premium53,629,000,000USD0001071739-21-000039
FY 2018Yearly · 2018-12-31ProductServices2,806,000,000USD0001071739-21-000039
FY 2018Yearly · 2018-12-31SegmentManaged Care56,999,000,000USD0001071739-21-000039
FY 2018Yearly · 2018-12-31SegmentSpecialty Services3,117,000,000USD0001071739-21-000039
FY 2017Yearly · 2017-12-31SegmentManaged Care45,798,000,000USD0001071739-20-000060
FY 2017Yearly · 2017-12-31SegmentSpecialty Services2,584,000,000USD0001071739-20-000060
FY 2016Yearly · 2016-12-31SegmentManaged Care38,182,000,000USD0001071739-19-000032
FY 2016Yearly · 2016-12-31SegmentSpecialty Services2,425,000,000USD0001071739-19-000032

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.